Date:March 02, 2013

Stacey Berg, MD

dr-stacey-bergAssociate Dean for Research Assurances
Baylor College of Medicine

Director, Palliative Care Program, and
Director, Developmental Therapeutics Program
Texas Children’s Cancer Center

Department of Pediatrics
Section of Hematology/Oncology
Baylor College of Medicine

Dr. Stacey Berg
1102 Bates Street, Suite 1550.06
Houston, TX 77030

Phone: 832-824-4588
Fax: 832-825-4039

About Dr. Stacey Berg

Dr. Stacey Berg’s primary area of interest is pharmacology and experimental therapeutics, with a special emphasis on the development of new anticancer drugs for children. In the laboratory, her interests include preclinical investigation of the pharmacokinetics of new agents. Drug concentrations are determined by high-pressure liquid chromatography or other appropriate methods. Data are analyzed with a variety of computer modeling strategies. These data facilitate the development of new therapies of children with cancer.

Dr. Stacey Berg is the Director of both the Developmental Therapeutics Program and the Palliative Care Program at Texas Children’s Cancer and Hematology Centers.

Research Interests

In addition to these, Dr. Stacey Berg also has a strong interest in clinical trial design, biomedical ethics, and the incorporation of palliative care principles into pediatric oncology practice.


A.B., Harvard University
M.D., University of Pittsburgh School of Medicine
Residency, Children’s Hospital of Pittsburgh
Fellowship, National Institutes of Health

Board Certifications

American Board of Pediatrics: Pediatric Hematology/Oncology
American Board of Pediatrics: Pediatrics
American Board of Pediatrics: Hospice and Palliative Medicine

Clinical Interests

New Drug Development
Hospice and Palliative Care